Skip to main content
SpringerLink
Log in

The significance of endotoxin release in experimental and clinical sepsis in surgical patients — Evidence for antibiotic-induced endotoxin release?

  • Review
  • Published:
Infection Aims and scope Submit manuscript

Summary

Sepsis and peritonitis remain a serious challenge for surgical patients, despite improvement in surgical therapy and intensive care and the introduction of new powerful antibiotics. Recentin vitro studies revealed the potential of certain antibiotics, e.g. penicillin-binding protein (PBP) 3-specific antibiotics, to cause antibiotic-induced endotoxin release. Other types of antibiotics, e.g., PBP 2-specific antibiotics, were associated with no or less endotoxin release. Furtherin vitro experiments and investigations in animals support the hypothesis of antibiotic-induced endotoxin release, but there is little clinical evidence. The clinical significance of endotoxin is subject of open dispute with many pro's and contra's. Endotoxin, although and important trigger, may not be the only factor to induce cytokine release, e.g., peptidoglycans were able to stimulate cells to release cytokines. Gram-positive pathogens have gained more importance in clinical sepsis and may not be sufficiently reflected in current clinical studies. The hypothesis that neutralization of endotoxin and proinflammatory cytokines is beneficial in sepsis was seriously challenged by the results of recent clinical and experimental studies. The better understanding of mechanisms in endotoxin-induced cell activation and cell, cell-receptor and soluble receptor interactions led to new treatment options. Recent reports on the complex pathogenesis of peritonitis and the detection of pathogen-related factors with intraperitoneal immune response may have implications on clinical studies investigating the potential of new compounds and the effect of antibiotics on endotoxin release. However, only few reports are available on the clinical significance of antibiotic-induced endotoxin release, and association of endotoxin release with pathogens, mortality or alteration of physiological parameters were not observed. With regard to the particulars of these studies, e.g., a small study population or low mortality rate, mortality may not be an ideal outcome parameter for these studies. There is clinical evidence for antibiotic-induced endotoxin release. However, the need for well-designed and performed studies using newly developed monitoring devices in intensive care therapy is obvious.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Stone, R.: Search for sepsis drugs goes on despite past failures. Science 264 (1994) 365–367.

    Article  PubMed  CAS  Google Scholar 

  2. Wittmann, D. H., Bansal, N., Bergstein, J. M., Wallance J. R., Wittmann, M. M., Aprahamian, C.: Staged abdominal repair compares favourably with conventional operative therapy for intraabdominal infections when adjusting for prognostic factors with a logistic model. Theor. Surg. 9 (1994) 201–207.

    Google Scholar 

  3. Wittmann, D. H., Schein, M., Condon, R. E.: Management of secondary peritonitis. Ann. Surg. 224 (1996) 10–18.

    Article  PubMed  CAS  Google Scholar 

  4. Kirschner, M.: Die Behandlung der akuten Bauchfellentzündung. Langenbecks. Arch. Klin. Chir. 142 (1926) 253–311.

    Google Scholar 

  5. Holzheimer, R. G., Cavaillon, J. M., Mosca, F., Haupt, W., Stefani, A., DiStefano, R., Torres, A., Capel, P., Aasen, A., Anderson, I., Schöffel, U.: Clinical and basic science aspects of immune pathogenesis of sepsis and peritonitis. Med. Microbiol. Letters 5 (1996) 386–393.

    Google Scholar 

  6. Michie, H. R., Wilmore, D. W.: Sepsis, signals and surgical sequelae (a hypothesis). Arch. Surg. 125 (1990) 531–536.

    PubMed  CAS  Google Scholar 

  7. Holzheimer, R. G., Steinmetz, W. G., Ebentreich, U., Kauffmann, T., Jendrissek, A., Franke, S., Engermann, R., Thiede, A.: Aortic aneurysm repair may cause bacterial translocation with concominant endotoxin release into the systemic circulation and activation of the inflammatory cascade. J. Endotoxin Research 1 (1994) 31.

    Google Scholar 

  8. Jackson, J. J., Kropp, H.: Beta-lactam antibiotic induced release of endotoxin:in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J. Infect. Dis. 165 (1992) 1033–1041.

    PubMed  CAS  Google Scholar 

  9. Seelen, M. A., Athanassion, P., Lynn, W. A., Norsworth, P., Walport, M. J., Cohen, J., Davies, K. A.: The anti-lipid A monoclonal antibody E5 binds to rough gram-negative bacteria, fixes C3, and facilitates binding of bacterial immune complexes to both erythrocytes and monocytes. Immunology 84: (1995) 653–661.

    PubMed  CAS  Google Scholar 

  10. Levy, O., Oos, E., Elsbach, P., Doerfler, M. E., Lehrer, R. I., Weiss, J.: Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability increasing protein, p15s, and defensins. J. Immunol. 154 (1995) 5403–5410.

    PubMed  CAS  Google Scholar 

  11. Crosby, H. A., Bion, J. F., Penn, C. W., Elliott, T. S.: Antibiotic-induced release of endotoxin from bacteriain vitro. J. Med Microbiol. 40 (1994) 23–30.

    Article  PubMed  CAS  Google Scholar 

  12. Bucklin, S. E., Fujihara, Y., Leeson, M. C., Morrison, D. C.: Differential antibiotic-induced endotoxin release from gram-negative bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 13 (Suppl. 1) (1994) 43–51.

    Article  Google Scholar 

  13. Foca, A., Matera, G., Berlinghieri, M. C.: Inhibition of endotoxin-induced interleukin 8 release by teicoplanin in human whole blood. Eur. J. Clin. Microbiol. Infect. Dis. 12 (1993) 940–944.

    Article  PubMed  CAS  Google Scholar 

  14. Burd, R. S., Battafarano, R. J., Cody, C. S., Farber, M. S., Ratz, C. A., Dunn, D. L.: Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-alpha by two different mechanisms. Ann. Surg. 218 (3) (1993) 250–259.

    Article  PubMed  CAS  Google Scholar 

  15. Dofferhoff, A. S., Esselink, M. T., de Vries Hospers, H. G., van Zanten, A., Bom, V. J., Weits, J., Vellenga, E.: The release of endotoxin from antibiotic-treatedEscherichia coli and the production of tumor necrosis factor by human monocytes. J. Antimicrob. Chemother. 31 (1993) 373–384.

    Article  PubMed  CAS  Google Scholar 

  16. Eng, R. H., Smith, S. M., Fan Harvard, P., Ogbara, T.: Effect of antibiotics on endotoxin release from gram-negative bacteria. Diagn. Microbiol. Infect. Dis. 16 (3) (1993) 185–189.

    Article  PubMed  CAS  Google Scholar 

  17. Arditi, M., Kabat, W., Yogev, R.: Antibiotic-induced bacterial killing stimulates tumor necrosis factor-alpha release in whole blood. J. Infect. Dis. 167 (1993) 240–244.

    PubMed  CAS  Google Scholar 

  18. Van den Berg, C., de Neeling, A. J., Schot, C. S., Hustinx, W. N., Wemer, J., de Wildt, D. J.: Delayed antibiotic-induced lysis ofEscherichia coli in vitro is correlated with enhancement of LPS release. Scand. J. Infect. Dis. 24 (1992) 619–627.

    Article  Google Scholar 

  19. Bingen, E., Goury, V., Bennani, H., Lambert Zechovsky, N., Aujard, Y., Darbord, J. C.: Bactericidal activity of beta-lactams and amikacin againstHaemophilus influenzae: effect on endotoxin release. J. Antimicrob. Chemother. 30 (1992) 165–172.

    Article  PubMed  CAS  Google Scholar 

  20. Dofferhoff, A. S., Nijland, J. H., de Vries Hospers, H. G., Mulder, P. O., Weits, J., Bom, V. J.: Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: anin-vitro andin-vivo study. Scan. J. Infect. Dis. 23 (1991) 745–754.

    Article  CAS  Google Scholar 

  21. Simon, D. M., Koenig, G., Trenholme, G. M.: Differences in release of tumour necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killedEscherichia coli. J. Infect. Dis. 164 (1991) 800–802.

    PubMed  CAS  Google Scholar 

  22. Morrison, D. C., Bucklin, S. E., Leeson, M. C., Norimatsu, M.: Contribution of soluble endotoxin release from gram-negative bacteria by antibiotics to the pathogenesis of experimental sepsis in mice. J. Endotoxin Research 3 (1996) 237–243.

    Article  CAS  Google Scholar 

  23. Bucklin, S. E., Morrison, D. C.: Differences in therapeutic efficacy among cell wall active antibiotics in a mouse model of gram-negative sepsis. J. Infect. Dis. 172 (1995) 1519–1527.

    PubMed  CAS  Google Scholar 

  24. Opal, S. M., Horn, D. L., Palardy, J. E., Parejo, N., Jhung, J., Battacharjee, A., Young, L. D.: Thein vivo significance of antibiotic-induced endotoxin release in experimental gram-negative sepsis. J. Endotoxin Research 3 (1996) 245–252.

    Article  CAS  Google Scholar 

  25. Cohen, J., McConnell, J. S.: Release of, endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B. Eur. J. Clin. Microbiol. 5 (1986) 13–17.

    Article  PubMed  CAS  Google Scholar 

  26. Artenstein, A. W., Cross, A. S.: Inhibition of endotoxin reactivity by aminoglycosides. J. Antimicrob. Chemother. 24 (1989) 826–828.

    Article  PubMed  CAS  Google Scholar 

  27. Healy, D. P., Verst-Brasch, C. L., Clendening, C. E., Neely, A. N., Holder, I. A.: Influence of drug class and dose size on antibiotic induced endotoxin/IL-6 release and impact on efficacy of anti-endotoxin antibody. J. Endotoxin Research 3 (1996) 219–227.

    Article  CAS  Google Scholar 

  28. Lamp, K. C., Rybak, M. J., McGrath, B. J., Summers, K. K.: Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release fromEscherichia coli andPseudomonas aeruginosa. Antimicrob. Agents Chemother. 40 (1996) 247–252.

    PubMed  CAS  Google Scholar 

  29. Morrison, D. C., Bucklin, S. E.: Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis. Scand. J. Infect. Dis. Suppl. 101 (1996) 3–8.

    PubMed  CAS  Google Scholar 

  30. Nitsche, D., Schulze, C., Oesser, S., Dalhoff, A., Sack, M.: Impact of different classes antimicrobial agents on plasma endotoxin activity. Arch. Surg. 131 (1996) 192–199.

    PubMed  CAS  Google Scholar 

  31. Arditi, M., Zhou, J.: Differential antibiotic-induced endotoxin release and interleukin-6 production by human umbilical vein endothelial cells (HUVECs): amplification of the response by coincubation of HUVECs and blood cells. J. Infect. Dis. 175 (1997) 1255–1258.

    PubMed  CAS  Google Scholar 

  32. Hurley, J. C.: Antibiotic-induced release of endotoxin: a reppraisal.Clin. Infect. Dis. 15 (1992) 840–854.

    PubMed  CAS  Google Scholar 

  33. Casey, L. C., Balk, R. A., Bone, R. C.: Plasma cytokine, and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119 (1993) 771–778.

    PubMed  CAS  Google Scholar 

  34. Bellomo, R.: The cytokine network in the critically ill. Anaesth. Intensive Care 20 (1992) 288–302.

    PubMed  CAS  Google Scholar 

  35. Goris, R. J.: Mediators of multiple organ failure. Intensive Care Med. 16 (Suppl. 3) (1990) S192-S196.

    Article  PubMed  Google Scholar 

  36. van der Poll, T., Van Deventer, S. J., ten Cate, H., Levi, M., ten Cate, J. W.: Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia. J. Infect. Dis. 169 (1994) 665–667.

    PubMed  Google Scholar 

  37. Leeson, M. C., Fujihara, Y., Morrison, D. C.: Evidence for lipopolysaccharide as the predominant proinflammatory mediator in supernatants of antibiotic-treated bacteria. Infect. Immun. 62 (1994) 4975–4980.

    PubMed  CAS  Google Scholar 

  38. Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., Sibbald, W. J.: Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101 (1992) 1644–1655.

    Article  PubMed  CAS  Google Scholar 

  39. Wewers, M. D., Rinehart, J. J., She, Z. W., Herzyk, D. J., Hummel, M. M., Kinney, P. A., Davis, W. B.: Tumor necrosis factor infusions in humans prime neutrophils for hypochlorous acid production. Am. J. Physiol. 259 (1990) L276–282.

    PubMed  CAS  Google Scholar 

  40. Cohen, J., Carlet, J. andthe Intersept Study Group: Intersept: an international multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-α in patients with sepsis. Crit. Care. Med. 24 (1996) 1431–1440.

    Article  PubMed  CAS  Google Scholar 

  41. Morrison, D. C.: Assessment of antibiotic-mediated endotoxin release. J. Endotoxin Research 3 (1996) 275–279.

    Article  Google Scholar 

  42. Kelly, J. L., O'Sullivan, C., O'Riordain, M., O'Riordain, D., Lyons, A., Doherty, J., Mannick, J. A., Rodrick, M. L.: Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury? Ann. Surg. 225 (1997) 530–541.

    Article  PubMed  CAS  Google Scholar 

  43. Willatts, S. M., Speller, D. C., Winter, R. J.: Incidence of gram-negative bacteremia in sepsis syndrome. Implications for immunotherapy. Anaesthesia 49 (1994) 751–754.

    Article  PubMed  CAS  Google Scholar 

  44. Schöffel, U., Jacobs, E., Ruf, G., Mierswa, F., von Specht, B. U., Farthmann, E. H.: Intraperitoneal microorganisms and the severity of peritonitis. Eur. J. Surg. 161 (1995) 501–508.

    Google Scholar 

  45. Berger, D., Schmidt, U. M., Ott, S., Seidelmann, M., Martin, R., Beger, H. G.: Incidence and pathophysiological relevance of postoperative endotoxemia. FEMS Immunol. Med. Microbiol. 11 (1995) 285–290.

    Article  PubMed  CAS  Google Scholar 

  46. Berger, D., Boelke, E., Seidelmann, M., Berger, H. G.: Evaluation of endotoxemia for diagnosis of urinary tract infection after major surgical procedures. Clin. Chim. Acta 244 (1996) 155–190.

    Article  PubMed  CAS  Google Scholar 

  47. Michie, H. R., Manogue, K. R., Spriggs, D. R.: Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318 (1988) 1481–1486.

    Article  PubMed  CAS  Google Scholar 

  48. Rintala, E., Pulkki, K., Mertsola, J., Nevalainen, T., Nikoskelainen, J.: Endotoxin, interleukin-6 and phospholipase A2 as markers of sepsis with hematological maligancies. Scand. J. Infect. Dis. 27 (1995) 39–43.

    PubMed  CAS  Google Scholar 

  49. Weidemann, B., Schletter, J., Dziarski, R., Kusumoto, S., Stelter, F., Rietschel, E. T., Flad, H. D., Ulmer, A. J.: Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect. Immun. 65 (1997) 858–864.

    PubMed  CAS  Google Scholar 

  50. Schromm, A. B., Brandenburg, K., Rietschel, E. T., Flad, H. D., Carroll, S. F., Seydel, U.: Lipopolysaccharide-binding protein mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranes. FEBS Lett. 399 (1996) 267–271.

    Article  PubMed  CAS  Google Scholar 

  51. Schletter, J., Brade, H., Brade, L., Kruger, C., Lopponow, H., Kusumoto, S., Rietschel, E. T., Flad, H. D., Ulmer, A. J.: Binding of lipopolysaccharide (LPS) to an 80-kilodalton membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein. Infect. Immun. 63 (1995) 2576–2580.

    PubMed  CAS  Google Scholar 

  52. Seydel, U., Brandenburg, K., Rietschel, E. T.: A case for an endotoxic conformation. Prog. Clin. Biol. Res. 388 (1994) 17–30.

    PubMed  CAS  Google Scholar 

  53. Flad, H. D., Lopponow, H., Rietschel, E. T., Ulmer, A. J.: Agonists and antagonists for lipolysaccharide-induced cytokines. Immunobiology 187 (1993) 303–316.

    PubMed  CAS  Google Scholar 

  54. Mattern, T., Thanhauser, A., Reilling, N., Toellner, K. M., Duchrow, M., Kusumoto, S., Rietschel, E. T., Ernst, M., Brade, H., Flad, H. D.: Endotoxin and lipid A stimulate proliferation of human T cells in the presence of autologous monocytes. J Immunol. 153 (1994) 2996–3004.

    PubMed  CAS  Google Scholar 

  55. Bone, R. C., Balk, R. A., Fein, A. M., Perl, T. M., Wenzel, R. P., Reines, H. D., Quener, R. W., Iberti, T. J., Macintyre, N., Schein, R. M.: A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized controlled trial. The E5 sepsis study group. Crit. Care Med. 23 (1995) 994–1006.

    Article  PubMed  CAS  Google Scholar 

  56. Marra, M. N., Thornton, M. B., Snable, J. L., Wilde, C. G., Scott, R. W.: Endotoxin-binding and-neutralizing properties of recombinant bacteridal/permeability increasing protein and monoclonal antibodies HA-1A and E5. Crit. Care Med. 22 (1994) 559–565.

    Article  PubMed  CAS  Google Scholar 

  57. Christ, W. J., Asano, O., Robidoux, A. L., Perez, M., Wang, Y., Dubuc, G. R., Gavin, W. E., Hawkins, L. D., McGuiness, P. D., Mullarkey, M. A.: E5531, a pure endotoxin antagonist of high potency. Science 268 (1995) 80–83.

    Article  PubMed  CAS  Google Scholar 

  58. DiPadova, F. E., Brade, H., Barclay, G. R., Poxton, I. R., Liehl, E., Schuetze, E., Kocher, H. P., Ramsay, G., Schreier, M. H., McClelland, D. B.: Abroadly cross-protective monoclonal antibody binding toE. coli andSalmonella lipopolysaccharides. Infect. Immun. 61 (1993) 3863–3872.

    CAS  Google Scholar 

  59. Kuhn, H. M., Brade, L., Appelmelk, B. J., Kusumoto, S., Rietschel, E. T., Brade, H.: The antibody reactivity of monoclonal lipid A antibodies is influenced by the acylation pattern of lipid A and the assay system employed. Immunobiology 189 (1993) 457–471.

    PubMed  CAS  Google Scholar 

  60. Goldie, A. S., Fearon, K. C., Ross, J. A., Barclay, G. R., Jackson, R. E., Grant, I. S., Ramsay, G., Blyth, A. S., Howie, J. C.: Natural cytokine antagonist and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. JAMA 274 (1995) 172–177.

    Article  PubMed  CAS  Google Scholar 

  61. Bennett Guerrero, E., Ayuso, L., Hamilton Davis, C., White, W. D., Barclay, G. R., Smith, P. K., King, S. A., Muhlbaier, L. H., Newman, M. F., Mythen, M. G.: Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA 277 (1997) 646–650.

    Article  PubMed  CAS  Google Scholar 

  62. Urbaschek, B., Ditter, B., Becker, K. P., Urbaschek, R. Protective effects and role of endotoxin in experimental septicemia. Circ. Shock 14 (2984) 209–222.

  63. Urbaschek, R., Becker, K. P.: Endotoxinnachweis im Plasma: Spezifität und Aussagekraft für Entwicklung und Prognose einer Sepsis. Infusionsther. Transfusionsmed. 20 (Suppl. 1) (1993) 16–20.

    PubMed  Google Scholar 

  64. Nishida, J., Ekataksin, W., McDonnell, D., Urbaschek, R., Urbaschek, B., McCuskey, R. S.: Ethanol exacerbates hepatic microvascular endotoxemia and lethality in septic mice. Schock 1 (1994) 413–418.

    CAS  Google Scholar 

  65. Prins, J. M., Kuijper, E. J., Mevissen, M. L. C. M., Speelman, P., van Deventer, S. J. H.: Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing ofEscherichia coli in whole blood: of antibiotic class, antibiotic concentration and presence of septic serum. Infect. Immun. 63 (1995) 2235–2242.

    Google Scholar 

  66. Patel, R. T., Deen, K. L., Youngs, D., Warwick, J., Keighley, M. R.: Interleukin 6 is a prognostic indicator of outcome in severe intraabdominal sepsis. Br. J. Surg. 81 (1994) 1306–1308.

    Article  PubMed  CAS  Google Scholar 

  67. de Bont, E. S., Martens, A., van Raan, J., Samson, G., Fetter, W. P., Okken, A., de Leij, L. H., Kimpen, J. L.: Diagnostic value of plasma levels of tumor necrosis factor alpha (TNF alpha) and interleukin-6 (IL-6) in newborns with sepsis. Acta Paediatr. 83 (1994) 696–699.

    Article  PubMed  Google Scholar 

  68. Fugger, R., Zadrobilek, E., Gotzinger, P., Klimann, S., Rogy, M., Winkler, S., Andel, H., Mittelbrock, M., Roth, E., Schulz, F.: Perioperative TNF alpha and IL-6 concentrations correlate with septic state, organ function, and Apache II scores in intraabdominal infection. Eur. J. Surg. 159 (1993) 525–529.

    PubMed  CAS  Google Scholar 

  69. Holzheiner, R. G., Schein, M., Wittmann, D. H.: Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe, pertonitis. Arch. Surg. 130 (1995) 1314–1320.

    Google Scholar 

  70. Holzheimer, R. G., Cavaillon, J. M., Aasen, A. O., Cainzos, M., Schöffel, U.: Clinical routine determination as part of a European Research Network. Shock 7 (1997) 121.

    Google Scholar 

  71. Echtenacher, B., Falk, W., Männel, D. N., Krammer, P. H.: Requirements of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J. Immunol. 145 (1990) 3762–3766.

    PubMed  CAS  Google Scholar 

  72. Bagby, G. J., Plessala, K. J., Wilson, L. A., Thompson, J. J., Nelson, S.: Divergent efficacy of antibody to tumor necrosis factor alpha in intravascular and peritonitis models of sepsis. J. Infect. Dis. 163 (1991) 83–88.

    PubMed  CAS  Google Scholar 

  73. Villa, P., Sartor, G., Angelini, M., Sironi, M., Conni, M., Gnocchi, P., Isetta, A. M., Grau, G., Buurman, W., van Tits, L. J.: Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin. Clin. Diagn. Lab. Immunol. 2 (1995) 549–553.

    PubMed  CAS  Google Scholar 

  74. Schein, M., Wittmann, D. H., Holzheimer, R., Condon, R. E.: Hypothesis: compartmentalization of cytokines in intraabdominal infection. Surgery 119 (1996) 694–700.

    Article  PubMed  CAS  Google Scholar 

  75. Holzheimer, R. G., Molloy, R., Mendez, M. V., O'Riordain, D., Curley, P., Nestor, M., Collins, K., Saporoschetz, I., Mannick, J. A., Rodrick, M. L.: Multiple system organ failure may be influenced by macrophage hypoactivation as well as hyperactivation—importance of the double challenge. Eur. J. Surg. 161 (1995) 795–803.

    PubMed  CAS  Google Scholar 

  76. Hau, T., Ahrenholz, D. H., Simmons, R. L.: Secondary bacterial peritonitis: the biological basis of treatment. Curr. Probl. Surg. 16 (1979) 1.

    Article  PubMed  CAS  Google Scholar 

  77. Hau, T., Mozes, M. F., Jonasson, O.: Peritonitis nach Nierentransplantation. Langenbecks Arch. Chir. 353 (1981) 269.

    Article  PubMed  CAS  Google Scholar 

  78. Holzheimer, R. G., Quoika, P., Pätzmann, D., Füssle, R.: Nosocomial infections in general surgery: surveillance report from a German university clinic. Infection 18 (1990) 219–225.

    Article  PubMed  CAS  Google Scholar 

  79. Christou, N. V., Turgeon, P., Wassef, R., Rotstein, O., Bohnen, J., Potvin, M.: Management of intraabdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intraabdominal Infection Study Group. Arch. Surg. 131 (1996) 1193–1201.

    PubMed  CAS  Google Scholar 

  80. Cross, A., Asher, L., Seguin, M., Yuan, L., Kelly, N., Hammack, C., Sadoff, J., Gemski, P.: The importance of lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasiveEschierichia coli. J. Clin. Invest. 96 (1995) 676–686.

    PubMed  CAS  Google Scholar 

  81. Prins, J. M., Kuijpers, E. J., Mevissen, M. L., Speelman, P., van Deventer, S. J.: Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing ofEscherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infect. Immun. 63 (1995) 2236–2242.

    PubMed  CAS  Google Scholar 

  82. Rosman, C., Westerveld, G. J., van Oeveren, W., Kooi, K., Bleichrodt, R. P.: Effect of intraperitoneal microbials on the concentration of bacteria, endotoxin, and tumor necrosis factor in abdominal fluid and plasma in rats. Eur. Surg. Res. 28 (1996) 351–360.

    Article  PubMed  CAS  Google Scholar 

  83. Hurley, J. C.: Antibiotic-induced release of endotoxin. A therapeutic paradox. Drug Saf. 12 (1995) 183–195.

    Article  PubMed  CAS  Google Scholar 

  84. Stone, H. H., Kolb, L. D., Geheber, C. E.: Incidence and significance of intraabdominal infections. Ann. Surg. 181 (1975) 705–715.

    Article  PubMed  CAS  Google Scholar 

  85. Lorber, H. H., Swenson, R. M.: The bacteriology of intraabdominal infection. Surg. Clin. North Am. 55 (1975) 1349–1354.

    PubMed  CAS  Google Scholar 

  86. Rotstein, O.: Pentonitis and intraabdominal abscesses. In:Meakins, J. L. (ed.): Surgical infections—diagnosis and treatment. Scientific American Medicine Inc., New York 1994, pp. 329–351.

    Google Scholar 

  87. Prins, J. M., van Agtmael, M. A., Kuijper, E. J., van Deventer, S. J., Speelman, P.: Antibiotic-induced endotoxin releaase in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J. Infect. Dis. 172 (1995) 886–891.

    PubMed  CAS  Google Scholar 

  88. Arditi, M., Ables, L., Yoger, R.: Cerebrospinal fluid endotoxin levels in children withH. influenzae meningitis before and after iv ceftriaxone. Infect. Dis. 160 (1990) 1005–1011.

    Google Scholar 

  89. Hurley, L. C., Louis, W. J., Tosolini, F. A., Carlin, J. B.: Antibiotic-induced release of endotoxin in chronically bacteriuric patients. Antimicrob. Agents Chemother. 35 (1991) 2388–2394.

    CAS  Google Scholar 

  90. Prins, J. M.: Antibiotic induced release of endotoxin—clinical data and human studies. J. Endotoxin Research 3 (1996) 269–273.

    Article  CAS  Google Scholar 

  91. Mock, C. N., Jurkovich, G. J., Dries, D. J., Maier, R. V.: Clinical significance of antibiotic endotoxin releasing properties in trauma patients. Arch. Surg. 130 (1995) 1234–1240.

    PubMed  CAS  Google Scholar 

  92. Holzheimer, R. G., Hirte, J. F., Reith, B., Engelhardt, W., Horak, K. H., Leppert, R., Aasen, A., Capel, P., Urbaschek, R., Karch, H., Thiede, A.: Different endotoxin release and IL-6 plasma levels after antibiotic administration in surgical intensive care patients. J. Endotoxin Research 3 (1996) 261–267.

    Article  CAS  Google Scholar 

  93. Morrison, D. C.: Assessment of antibiotic mediated endotoxin release. J. Endotoxin Research 3 (1996) 173–178.

    Article  Google Scholar 

  94. Brandenburg, K., Seydel, U., Schromm, A. B., Loppnow, H., Koch, M. H. J., Rietschel, E. T.: Conformation of lipid A, the endotoxic center of bacterial lipopolysaccharide. J. Endotoxin Research 3 (1996) 173–178.

    Article  CAS  Google Scholar 

  95. Opal, S. M., Horn, J. E., Palardy, J. E., Parejo, N., Jhung, J., Battacharjee, A., Young, L. D.: Thein vivo significance of antibiotic-induced endotoxin release in experimental gram-negative sepsis. J. Endotoxin Research 3 (1996) 245–252.

    Article  CAS  Google Scholar 

  96. Biffl, W. L., Moore, E. E., Moore, F. A., Peterson, V. M.: Interleukin 6 in the injured patient—marker of injury or mediator of inflammation? Ann. Surg. 224 (1996) 647–664.

    Article  PubMed  CAS  Google Scholar 

  97. Tang, G. J., Kuo, C. D., Yen, T. C., Kuo, H. S., Chan, K. H., Yien, H. W., Lee, T. Y.: Perioperative plasma concentrations of tumor necrosis factor-alpha and interleukin-6 in infected patients. Crit. Care Med. 24 (1996) 423–428.

    Article  PubMed  CAS  Google Scholar 

  98. Wittmann, D. H.: Immunological consequences of antibiotic therapy. In:Engemann, R., Holzheimer, R. G., Thiede, A. (eds): Immunology and its impact on infections in surgery. Springer Verlag, Heidelberg Berlin New York 1995, pp. 217–223.

    Google Scholar 

  99. Astiz, M. E., Rackow, E. C., Still, J. G., Howell, S. T., Cato, A., Von Eschen, K. B., Ulrich, J. T., Rudbach, J. A., McMahon, G., Vargas, R.: Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial. Crit. Care Med. 23 (1995) 9–17.

    Article  PubMed  CAS  Google Scholar 

  100. Bone, R. C., Balk, R. A., Fein, A. M., Perl, T. M., Wenzel, R. P., Reines, H. D., Quenzer, R. W., Iberti, T. J., MacIntyre, N., Schein, R. M.: A second large clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter randomized, controlled trial. The E5 Sepsis Study Group. Crit. Care Med. 23 (1995) 994–1006.

    Article  PubMed  CAS  Google Scholar 

  101. Greenman, R. L., Schein, R. M., Martin, M. A., Wenzel, R. P., MacIntyre, N. R., Emmanuel, G., Chmel, H., Kohler, R. B., McCarty, M., Plouffe, J.: A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA 266 (1991) 1097–1102.

    Article  PubMed  CAS  Google Scholar 

  102. Rogy, M. A., Oldenburg, H. S. A., Coyle, S., Trousdale, R., Moldawer, L. L., Lowry, S. F.: Correlation between acute physiology and chronic health evaluation (Apache) III score and immunological parameters in critically ill patients with sepsis. Br. J. Surg. 83 (1996) 396–400.

    Article  PubMed  CAS  Google Scholar 

  103. Holzheimer, R. G., Haupt, W., Thiede, A., Schwarzkopf, A.: The challenge of postoperative infections: does the surgeon make a difference? Infect. Control Hosp. Epidemiol 18 (1997) 449–456.

    Article  PubMed  CAS  Google Scholar 

  104. Imhof, M., Bauer, M.: Time series analysis in critical care monitoring. New Horizons 4 (1996) 519–531.

    Google Scholar 

  105. Aasen, A. O., Soiberg, R., Sveen, O., Gallimore, M. J., Holzheimer, R. G.: Consequences of trauma on circulating cells and the plasma cascade systems. In:Risberg, B.: Trauma care—an update. Pharmacia & Upjohn, Stockholm, Sweden 1996, 118–128.

    Google Scholar 

  106. Hesselvik, J. F., Blombäck, M., Brodin, B., Maller, R.: Coagulation. fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Crit. Care Med. 17 (1989) 724–733.

    Article  PubMed  CAS  Google Scholar 

  107. Aasen, A. O.: The proenzyme functional inhibition index. A new parameter for the evaluation of severely injured and septic patients. Acta Chir. Scand. Suppl. 522 (1985) 211–233.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Allgemeinchirurgie, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Str. 40, D-06097, Halle, Germany

    R. G. Holzheimer M.D., Ph.D.

Authors
  1. R. G. Holzheimer M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holzheimer, R.G. The significance of endotoxin release in experimental and clinical sepsis in surgical patients — Evidence for antibiotic-induced endotoxin release?. Infection 26, 77–84 (1998). https://doi.org/10.1007/BF02767765

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02767765

Keywords

Search

Navigation